Cite
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
MLA
King, Erin R., et al. “The Insulin-like Growth Factor 1 Pathway Is a Potential Therapeutic Target for Low-Grade Serous Ovarian Carcinoma.” Gynecologic Oncology, vol. 123, no. 1, Oct. 2011, pp. 13–18. EBSCOhost, https://doi.org/10.1016/j.ygyno.2011.06.016.
APA
King, E. R., Zu, Z., Tsang, Y. T. M., Deavers, M. T., Malpica, A., Mok, S. C., Gershenson, D. M., & Wong, K.-K. (2011). The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma. Gynecologic Oncology, 123(1), 13–18. https://doi.org/10.1016/j.ygyno.2011.06.016
Chicago
King, Erin R., Zhifei Zu, Yvonne T.M. Tsang, Michael T. Deavers, Anais Malpica, Samuel C. Mok, David M. Gershenson, and Kwong-Kwok Wong. 2011. “The Insulin-like Growth Factor 1 Pathway Is a Potential Therapeutic Target for Low-Grade Serous Ovarian Carcinoma.” Gynecologic Oncology 123 (1): 13–18. doi:10.1016/j.ygyno.2011.06.016.